Hemophilia News and Research

RSS
Hemophilia is a rare, inherited bleeding disorder in which your blood doesn’t clot normally. If you have hemophilia, you may bleed for a longer time than others after an injury. You also may bleed internally, especially in your knees, ankles, and elbows. This bleeding can damage your organs or tissues and, sometimes, be fatal.
Amsterdam Molecular Therapeutics reports 2009 half year financials

Amsterdam Molecular Therapeutics reports 2009 half year financials

NIH stimulus funding supports Emory - grants to advance research, create jobs, support students

NIH stimulus funding supports Emory - grants to advance research, create jobs, support students

Baxter completes production of batches of CELVAPAN A/H1N1 pandemic vaccine

Baxter completes production of batches of CELVAPAN A/H1N1 pandemic vaccine

Research supports world blood donor day message on blood safety

Research supports world blood donor day message on blood safety

Medgenics’ phase I/II clinical trial shows EPODURE continuous anemia treatment lasting 5 months in kidney disease patients

Medgenics’ phase I/II clinical trial shows EPODURE continuous anemia treatment lasting 5 months in kidney disease patients

New tissue engineering technique may help stem cells generate solid organs

New tissue engineering technique may help stem cells generate solid organs

Gene therapy for rheumatoid arthritis: promising results

Gene therapy for rheumatoid arthritis: promising results

CSL Behring receives FDA approval of RiaSTAP

CSL Behring receives FDA approval of RiaSTAP

A new method to control bleeding in hemophilia

A new method to control bleeding in hemophilia

FDA licenses Kogenate FS to prevent joint damage in children with hemophilia A

FDA licenses Kogenate FS to prevent joint damage in children with hemophilia A

Some Northern California colleges banning campus blood drives because of FDA's policy barring MSM

Some Northern California colleges banning campus blood drives because of FDA's policy barring MSM

Maxygen receives approval for trial of factor VIIa in UK

Maxygen receives approval for trial of factor VIIa in UK

CSL Behring study shows extended half-life recombinant VIIa leads to longer biologic activity

CSL Behring study shows extended half-life recombinant VIIa leads to longer biologic activity

Chemically modified protein may help people with hard-to-treat hemophilia

Chemically modified protein may help people with hard-to-treat hemophilia

An improved gene therapy agent from University of Florida

An improved gene therapy agent from University of Florida

FDA approves new formulation of genetically engineered version of Factor VIIa plasma protein

FDA approves new formulation of genetically engineered version of Factor VIIa plasma protein

Skin flaps deliver cancer-fighting therapy

Skin flaps deliver cancer-fighting therapy

Baxter International, Inc. wins patent infringement case

Baxter International, Inc. wins patent infringement case

Improved method for genetically manipulating human embryonic stem cells

Improved method for genetically manipulating human embryonic stem cells

Guidelines for von Willebrand disease diagnosis and management

Guidelines for von Willebrand disease diagnosis and management